Literature DB >> 3051560

Plasma exchange for recurrent nephrotic syndrome following renal transplantation.

J Laufer1, R B Ettenger, W G Ho, A H Cohen, J L Marik, R N Fine.   

Abstract

Patients with steroid-resistant nephrotic syndrome and focal segmental glomerulosclerosis (FGS) who develop end-stage renal disease are at risk for recurrence of the disease following renal transplantation. Recurrence of the nephrotic syndrome in renal allografts of two children with primary FGS was successfully controlled by plasma exchange. This report suggests that plasma exchange instituted early in the course of recurrent nephrotic syndrome may be beneficial in some patients with steroid-resistant nephrotic syndrome and FGS.

Entities:  

Mesh:

Year:  1988        PMID: 3051560     DOI: 10.1097/00007890-198810000-00014

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  15 in total

1.  Focal segmental glomerulosclerosis relapse after transplantation: treatment with high cyclosporine doses and a short plasmaphaeresis course.

Authors:  A Delucchi; F Cano; E Rodriguez; E Wolff
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

2.  Peritoneal protein losses in children with steroid-resistant nephrotic syndrome on continuous-cycler peritoneal dialysis.

Authors:  Sashikala Kopanati; Michel Baum; Albert Quan
Journal:  Pediatr Nephrol       Date:  2006-05-20       Impact factor: 3.714

3.  Treatment of recurrent idiopathic nephrotic syndrome after transplantation using plasmaphaeresis and intensified immunosuppression over 2 months.

Authors:  O H Oetliker; A Zimmermann; M G Bianchetti
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

4.  Single-center analysis of early recurrence of nephrotic syndrome following renal transplantation in children.

Authors:  A D Schachter; W E Harmon
Journal:  Pediatr Transplant       Date:  2001-12

5.  Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin Activation.

Authors:  Oliver Staeck; Torsten Slowinski; Ina Lieker; Kaiyin Wu; Birgit Rudolph; Danilo Schmidt; Susanne Brakemeier; Hans-Hellmut Neumayer; Changli Wei; Jochen Reiser; Klemens Budde; Fabian Halleck; Dmytro Khadzhynov
Journal:  Transplantation       Date:  2015-12       Impact factor: 4.939

6.  Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts.

Authors:  P Senggutuvan; J S Cameron; R B Hartley; S Rigden; C Chantler; G Haycock; D G Williams; C Ogg; G Koffman
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

7.  Early use of plasmapheresis for recurrent post-transplant FSGS.

Authors:  Madhura Pradhan; Julie Petro; Joanne Palmer; Kevin Meyers; H Jorge Baluarte
Journal:  Pediatr Nephrol       Date:  2003-06-26       Impact factor: 3.714

Review 8.  Recurrent glomerulonephritis after renal transplantation: an unsolved problem.

Authors:  William A Golgert; Gerald B Appel; Sundaram Hariharan
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 8.237

9.  Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide.

Authors:  P Cochat; A Kassir; S Colon; C Glastre; B Tourniaire; B Parchoux; X Martin; L David
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

Review 10.  Recurrent primary disease and de novo nephritis following renal transplantation.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.